Scarica l'app Stockscreener
9.27
1.59%
-0.15
Pre-mercato:
8.90
-0.37
-3.99%
Precedente Chiudi:
$9.42
Aprire:
$9.3
Volume 24 ore:
1.06M
Relative Volume:
1.02
Capitalizzazione di mercato:
$902.36M
Reddito:
$1.85M
Utile/perdita netta:
$-95.19M
Rapporto P/E:
-4.1742
EPS:
-2.2208
Flusso di cassa netto:
$-86.88M
1 W Prestazione:
-2.11%
1M Prestazione:
+28.04%
6M Prestazione:
+87.27%
1 anno Prestazione:
+131.17%
Intervallo 1D:
$9.23
$9.59
Intervallo di 1 settimana:
$9.05
$9.86
Portata 52W:
$2.85
$10.14
Anteris Technologies Global Corp Stock (AVR) Company Profile
Nome
Anteris Technologies Global Corp
Settore
Industria
Telefono
651-493-0606
Indirizzo
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
9.27 | 916.96M | 1.85M | -95.19M | -86.88M | -2.2208 |
ISRG
Intuitive Surgical Inc
|
417.07 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.16 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.84 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.09 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.94 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Ripresa | Cantor Fitzgerald | Overweight |
| 2026-03-11 | Iniziato | Wells Fargo | Overweight |
| 2025-01-08 | Iniziato | Lake Street | Buy |
| 2025-01-07 | Iniziato | Barclays | Overweight |
| 2025-01-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
Mostra tutto
Anteris Technologies Global Corp Borsa (AVR) Ultime notizie
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical InvestmentCore Business Growth - newsline.com
Funds from operations of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies (AVR) director exercises 17,580 RSUs into common shares - Stock Titan
Anteris (AVR) CFO exercises options, delivers 39,595 shares for taxes - Stock Titan
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: EPS Misses Estimates Significantly Amid Continued R&D InvestmentGAAP Earnings Report - newsline.com
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - marketscreener.com
Update: Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - Moomoo
Anteris Advances DurAVR Program Through ASX 300 Expansion - Kalkine Media
Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial - TradingView
Anteris Wins French Clearance to Expand Global DurAVR Heart Valve Trial - TipRanks
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial - Yahoo Finance
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment - marketscreener.com
Anteris Technologies Global Corp. Receives French Regulatory Clearance for Duravr Transcatheter Heart Valve Global Pivotal Trial - marketscreener.com
Anteris Technologies Global Receives French Regulator's Approval for DurAVR Trial in Aortic Stenosis - marketscreener.com
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance - The Manila Times
Why Is Anteris Technologies (ASX: AVR) Trading Near a 52-Week High? - Kalkine
Insider Scoop: Major Director Buy Signals Fresh Confidence in Anteris Technologies Global Corp. - TipRanks
Anteris Director Susan Knight Buys First Stake in Company - TipRanks
Anteris Investors Shift From ASX CDIs to Nasdaq Common Stock in May - TipRanks
Anteris Technologies (AVR) director purchases 11,000 shares in open market - Stock Titan
Why Is Anteris Technologies Global Corp. (AVR) Stock Up Today? - Meyka
Anteris Options Lapse, Trimming Potential Future Dilution - TipRanks
Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR) - The Globe and Mail
Anteris (NASDAQ: AVR) signs $250M at-the-market sales agreement with TD Cowen - Stock Titan
ChartWatch ASX scans: Brazilian Rare Earths, Echoiq, Weebit Nano, Anteris Technologies, Global X Semiconductor ETF - MSN
AVR - Finviz
Anteris Technologies Global Corp. Q1 2026 Earnings: EPS Misses Expectations as Stock RisesWeak Earnings Momentum - The Legal Advocate
Anteris launches $250m at-the-market program to fund structural heart push - TipRanks
Anteris Technologies Global Corp plans to issue up to $250 million in common stock through TD Cowen as the underwriter. - Bitget
Anteris Technologies Global Launches $250 Million ATM Offering Under Sales Agreement With TD Cowen - TradingView
Anteris (NASDAQ: AVR) launches $250M at-the-market share program - Stock Titan
Anteris Technologies (NASDAQ: AVR) establishes $250M ATM with TD Cowen - Stock Titan
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Pre-Revenue Biotech Posts Wider-Than-Expected Loss, Stock Rallies on Pipeline OptimismCash Flow Report - newsline.com
ChartWatch ASX Scans: Brazilian Rare Earths, Echoiq, Weebit Nano. Anteris Technologies, Global X Semiconductor ETF - Market Index
Anteris Technologies Global : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
Director Susan Knight reports initial insider status at Anteris (NASDAQ: AVR) - Stock Titan
Number of shareholders of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Stephen Denaro details indirect Anteris (AVR) share and option holdings - Stock Titan
Nantahala holds 6,143,154 shares of Anteris (AVR) as of 03/31/2026 - Stock Titan
AVR Maintained by Barclays -- Price Target Raised to $18.00 - GuruFocus
We Think Anteris Technologies Global (ASX:AVR) Can Afford To Drive Business Growth - simplywall.st
Anteris Technologies Global Corp. (AVR) Gets a Buy from TD Cowen - The Globe and Mail
Anteris Announces Results for the First Quarter of 2026 - Sahm
Anteris Technologies Adds Experienced Financial Leaders to Board - The Globe and Mail
TradingKey - TradingKey
Here's Why We're Not Too Worried About Anteris Technologies Global's (ASX:AVR) Cash Burn Situation - Yahoo Finance
How Should Investors Value Anteris Technologies Global Corp (AVR - GuruFocus
Anteris Technologies appoints two directors to board - Investing.com
Anteris Technologies appoints two directors to board By Investing.com - Investing.com South Africa
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors - The Manila Times
Anteris Technologies Global Corp Azioni (AVR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anteris Technologies Global Corp Azioni (AVR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Knight Susan Elizabeth | Director |
Jun 02 '26 |
Buy |
9.29 |
11,000 |
102,228 |
11,000 |
| L1 Capital Pty Ltd | 10% Owner |
Jan 22 '26 |
Buy |
5.75 |
5,000,000 |
28,750,000 |
13,219,814 |
1.68%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):